ÂÜÀòÂÒÂ×

Erik Iverson is a seasoned leader in biotechnology and global health, currently serving as Chief Executive Officer at the Wisconsin Alumni Research Foundation (WARF) since July 2016 and as a Board Member at FLUGEN, INC. since January 2018. Iverson co-founded Afrigen Biologics in South Africa, focusing on vaccine development, and has held senior executive roles at the Infectious Disease Research Institute, overseeing business development and operations. Prior experience includes an associate general counsel position at the Bill & Melinda Gates Foundation, where involvement primarily centered on global health, and legal practice at Perkins Coie LLP and Lane Powell Spears Lubersky LLP, specializing in biotechnology, tax, and business law. Academic credentials include an LL.M in Taxation from New York University, a Juris Doctor from the University of North Dakota, and a Bachelor of Arts in Business Management and Political Science from Gustavus Adolphus College.